A qualitative study of how Danish drug consumption rooms influence health and well-being among people who use drugs

Harm Reduction Journal

Volumn 13, Issue 1, 2016, Pages

  Kappel, Nanna ^a   Toth, Eva ^a   Tegner, Jette ^a   Lauridsen, Sigurd ^b  

^a UNIVERSITY COLLEGE COPENHAGEN   (Denmark)

^b COWI ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DENMARK; DRUG CONSUMPTION ROOM; FEMALE; HARM REDUCTION; HEALTH CARE FACILITY; HEALTH PERSONNEL ATTITUDE; HEALTH STATUS; HUMAN; MALE; PARTICIPANT OBSERVATION; PATIENT REFERRAL; QUALITATIVE RESEARCH; SATISFACTION; SEMI STRUCTURED INTERVIEW; SOCIAL ACCEPTANCE; SUBSTANCE ABUSE; WELLBEING; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONFIDENTIALITY; DRUG DEPENDENCE TREATMENT; DRUG OVERDOSE; INFORMATION DISSEMINATION; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PREVENTIVE HEALTH SERVICE; PROFESSIONAL-PATIENT RELATIONSHIP; PSYCHOLOGY; PUBLIC RELATIONS; SELF CONCEPT; SKIN DISEASES, INFECTIOUS; SOCIAL WORK; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CONFIDENTIALITY; DENMARK; DRUG OVERDOSE; FEMALE; HARM REDUCTION; HEALTH STATUS; HUMANS; INFORMATION DISSEMINATION; INTERINSTITUTIONAL RELATIONS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PATIENT EDUCATION AS TOPIC; PROFESSIONAL-PATIENT RELATIONS; REFERRAL AND CONSULTATION; SELF CONCEPT; SKIN DISEASES, INFECTIOUS; SOCIAL WORK; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84975223724     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/s12954-016-0109-y     Document Type: Article

References (44)

1. Schäffer D, Stöver H, Weichert L. Drug consumption rooms in Europe models, best practice and challenges. 2014;1-19.
2. Hedrich D, Kerr T, Dubois-Arber F. Chap 11: drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. EMCDDA monographs harm reduction: evidence, impacts and challenges. Luxembourg: European Monitoring Centre for Drugs and Addiction; 2010. p. 305-31.
3. EMCDDA. Drug consumption rooms: an overview of provision and evidence. 2015.
4. Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A. Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction. 2009;104:614-9.
5. DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, Montaner J, Wood E. Injection drug use cessation and use of North America's first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2-3):172-6.
6. Fast D, Small W, Wood E, Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduct J. 2008;5:32-7517-5-32.
7. Kinnard EN, Howe CJ, Kerr T, Hass VS, Marshall BDL. Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen. Denmark Harm Reduct J. 2014;11(1):29.
8. Marshall B, Milloy M, Wood E, Montaner J, Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377:1429-37.
9. Milloy M-S, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility. Plos One. 2008;3(10), e3351.
10. Scherbaum N, Specka M, Bombeck J, Marrziniak B. Drug consumption facility as part of a primary health care centre for problem drug users-which clients are attracted? Int J Drug Policy. 2009;20:447-9.
11. Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf). 2007;29(1):35-9.
12. Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29(2):126-30.
13. Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. Int J Drug Policy. 2008;19(3):183-8.
14. Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am. 2002;16(3):697-712.
15. Coull AF, Atherton I, Taylor A, Watterson AE. Prevalence of skin problems and leg ulceration in a sample of young injecting drug users. Harm Reduct J. 2014;11:22-7517-11-22.
16. Salmon AM, Dwyer R, Jauncey M, van Beek I, Topp L, Maher L. Injecting-related injury and disease among clients of a supervised injecting facility. Drug Alcohol Depend. 2009;101(1-2):132-6.
17. Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Determinants of cutaneous injection-related infection care at a supervised injecting facility. Ann Epidemiol. 2009;19(6):404-9.
18. Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner JSG, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J. 2005, 2(24)
19. National Board of Health. The drug situation in Denmark 2014. 2014
20. McNeil R, Small W. 'Safer environment interventions': a qualitative synthesis of the experiences and perceptions of people who inject drugs. Soc Sci Med. 2014;106:151-8.
21. Kerr T, Small W, Moore D, Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. Int J Drug Policy. 2007;18(1):37-45.
22. Fairbairn N, Small W, Shannon K, Wood E, Kerr T. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility. Soc Sci Med. 2008;67(5):817-23.
23. Rance J, Fraser S. Accidental intimacy: transformative emotion and the Sydney Medically Supervised Injecting Centre. Contemp Drug Prob. 2011;38:121-45.
24. Small W, Wood E, Lloyd-Smith E, Tyndall M, Kerr T. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug Alcohol Depend. 2008;98(1-2):159-62.
25. Ministry of the Interior and Health. The fight against drugs-program against narcotics. 2003
26. Ministry of the Interior and Health. The fight against drugs II. 2010
27. Ege PP. Supervised injecting facilities, voluntary action and civil disobedience. Ugeskr Laeger. 2012;174(39):2284.
28. Ministry of Health and Prevention. Bill amending the law on psychedelic substances (drug consumption room). 2011
29. Ministry of Health and Prevention, Denmark. Evaluation of existing drug consumption rooms. 2015
30. Goffman E. Stigma notes on the management of spoiled identity. 1986th ed. New York: Simon & Schuster; 1963.
31. Becker HS. Outsiders: studies in the sociology of deviance. New York: The Free Press, Simon & Schuster Inc.; 1963
32. Wind G. Negotiated interactive observation: doing fieldwork in hospital settings. Anthropol Med. 2008;15(2):79-89.
33. Bogdewic SP. Participant observation. In: Crabtree BF MW, editor. Doing qualitative research. 2nd ed. London, New Delhi: Thousand Oaks, Sage; 1999. p. 47-71.
34. Tjørnhøj-Thomsen T, Whyte S. Feltarbejde og deltagerobservation. In: Vallgårda S, Koch L, editors. Forskningsmetoder i folkesundhedsvidenskab. 3rd ed. København: Munksgaard Danmark; 2007. p. 87-115.
35. Ritchie J, Lewis J, Elam G, Tennant R, Rahim N. Designing and selecting samples. In: Ritchie J, Lewis J, Nicholls CM, Ormston R, editors. Qualitative research practice: a guide for social science students and researchers. Los Angeles, London, New Delhi, Singapore, Washington DC: Sage; 2014. p. 111-45.
36. International QSR. NVivo qualitative analysis software. 2012.
37. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24:105-12.
38. Houborg E, Asmussen Frank V, Bjerge B. From zero tolerance to non-enforcement: creating a new space for drug policing in Copenhagen, Denmark. Contemp Drug Prob. 2014;41(1):261.
39. Thiesen H, Hvidt C, Petersen H. Instrukser for de sundhedsfaglige ydelser i stofindtagelsesrum i Københavns Kommune. 2012
40. Small W, Rhodes T, Small W, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy. 2007;18(1):27-36.
41. Lee HS, Petersen SR. Demarginalizing the marginalized in substance abuse treatment: stories of homeless, active substance users in an urban harm reduction based drop-in center. Addict Res Theory. 2009;17(6):622-36.
42. Woods S. Drug consumption rooms in Europe organisational overview. 2014
43. National Board of Health. Drug situation in Denmark. 2015
44. Kappel N. Challenging meetings: an investigation of meetings between nurses and hospitalized drug users in medical wards. Roskilde University; 2009